Delivery Order SPE2DB22D3004-SPE2DB25FSF62
- Not listed
- The Defense Logistics Agency awarded a $1,943.94 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10mL units), with an ultimate completion date of August 27, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,267.94 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) under a firm fixed price contract. This award, announced on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10 mL) with a ceiling value of $1,472.06. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, issued on September 8, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,177.75 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML vials (10 ML) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,130.64 to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML vials (10 ml) on September 10, 2025, with completion scheduled for September 11, 2025. This competitive award with firm fixed pricing represents a small-value pharmaceutical procurement utilizing no set-aside designation. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and falls under the company's existing...
- The Defense Logistics Agency awarded a $1,113.80 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10mL) on June 5, 2025, with an ultimate completion date of June 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations for federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Humalog 100 Unit/mL vial 10mL insulin medication. The contract is valued at $4,766.40 with a firm fixed price structure and an ultimate completion date of September 22, 2025. This delivery order was competitively awarded without set-aside designation and represents a child...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,565.99, is for the delivery of Humalog 100 Unit/mL Vial 10mL, a medication used to treat diabetes. The contract is a delivery order, with a firm fixed price, and has an ultimate completion date of May 8, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,524.39, is for the delivery of Humalog 100 unit/mL vial, 10 mL. The contract is a firm fixed price type and has a completion date of June 7, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.96 firm fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has an ultimate completion date of May 8, 2023 and was awarded on May 5, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSF62Delivery Order
This delivery order, valued at $1,025.32, awards AmerisourceBergen Drug Corp the supply of Humalog 100 Unit/mL vials (10 mL) for the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement to support federal healthcare needs, specifically diabetes medication supply for military and defense-related healthcare systems. This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's position as a prime pharmaceutical vendor reflects its capability to meet federal procurement requirements through open competition and deliver critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/29/25 |